{"schema_version":"secwatch.filing_event.v1","accession":"0000950142-22-002215","form_type":"8-K","ticker":"VTVT","cik":"0001641489","company_name":"vTv Therapeutics Inc.","filed_at":"2022-07-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:56.497114+00:00","generated_at":"2026-06-24T14:08:22.272047+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"vTv Therapeutics appoints Dr. Keith Harris and Dr. Fahed Al Marzooqi to board","bullets":["Dr. Keith Harris appointed as Board member and chair of Audit Committee; Dr. Fahed Al Marzooqi appointed as Board member.","Dr. Harris is a London-based investment banker with 30-year career at Morgan Grenfell, Drexel Burnham, Apax, and HSBC.","Dr. Al Marzooqi is COO of G42 Healthcare; his appointment follows the May 2022 stock purchase agreement with G42 Investments.","Each new director receives $35k annual cash, 25,000 options upon appointment, plus 25,000 options in annual equity grants.","Dr. Harris qualifies as independent and as an audit committee financial expert under SEC rules."],"urls":{"canonical":"https://secwatch.observer/filing/0000950142-22-002215","json":"https://secwatch.observer/filing/0000950142-22-002215.json","markdown":"https://secwatch.observer/filing/0000950142-22-002215.md","text":"https://secwatch.observer/filing/0000950142-22-002215.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641489/000095014222002215/0000950142-22-002215-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641489/000095014222002215/eh220270165_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-24T14:08:22.272047+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e6c0aeee7","claim":"Dr. Keith Harris was appointed as member of the Board and a member and chair of the Audit Committee of the Board at vTv Therapeutics Inc..","evidence_excerpt":"appointed (i) Dr. Keith Harris as a member of the Board and a member and chair of the Audit Committee of the Board, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1641489/000095014222002215/0000950142-22-002215-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"member of the Board and a member and chair of the Audit Committee of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}